Inter-Institutional Pathology Consultation: The Importance of Breast Pathology Subspecialization in a Setting of Tertiary Cancer Center

Breast Journal

Volumn 21, Issue 4, 2015, Pages 337-344

  Soofi, Yousef ^a   Khoury, Thaer ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

breast biopsy; discordant rate; inter institutional consultation; quality assurance

Indexed keywords

ADULT; BIOPSY; BREAST NEOPLASMS; CANCER CENTER; CANCER STAGING; CLASSIFICATION; DIAGNOSTIC ERROR; FEMALE; HUMAN; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATHOLOGY; PATIENT REFERRAL; PROCEDURES;

ADULT; BIOPSY; BREAST NEOPLASMS; CANCER CARE FACILITIES; DIAGNOSTIC ERRORS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; ONCOLOGY SERVICE, HOSPITAL; PATHOLOGY, CLINICAL; PATHOLOGY, SURGICAL; REFERRAL AND CONSULTATION;

EID: 84934442616     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/tbj.12420     Document Type: Article

References (37)

1. Rosen PP,. Review of "outside" pathology before treatment should be mandatory [letter]. Am J Surg Pathol 2002; 26: 1235-6.
2. Kronz JD, Westra WH, Epstein JI,. Mandatory second opinion surgical pathology at a large referral hospital. Cancer 1999; 86: 2426-35.
3. Tomaszewski JE, LiVolsi VA,. Mandatory second opinion of pathologic slides, Is it necessary? Cancer 1999; 86: 2198-200.
4. Price JA, Grunfeld E, Barnes PJ, Rheaume DE, Rayson D,. Inter-institutional pathology consultations for breast cancer: impact on clinical oncology therapy recommendations. Curr Oncol 2010; 17: 25-32.
5. Swapp RE, Aubry MC, Salomao DR, Cheville JC,. Outside case review of surgical pathology for referred patients: the impact on patient care. Arch Pathol Lab Med 2013; 137: 233-40.
6. Manion E, Cohen MB, Weydert J,. Mandatory second opinion in surgical pathology referral material: clinical consequences of major disagreements. Am J Surg Pathol 2008; 32: 732-7.
7. Bajaj J, Morgenstern N, Sugrue C, Wasserman J, Wasserman P,. Clinical impact of second opinion in thyroid fine needle aspiration cytology (FNAC): a study of 922 interinstitutional consultations. Diagn Cytopathol 2012; 40: 422-9.
8. Bomeisl PE Jr, Alam S, Wakely PE Jr,. Interinstitutional consultation in fine-needle aspiration cytopathology. Cancer Cytopathol 2009; 117: 237-46.
9. Tsung JSH,. Institutional pathology consultation. Am J Surg Pathol 2004; 28: 399-402.
10. Weir MM, Jan E, Colgan TJ,. Interinstitutional pathology consultations a reassessment. Am J Clin Pathol 2003; 120: 405-12.
11. Westra WH, Kronz JD, Eisele DW,. The impact of second opinion surgical pathology on the practice of head and neck surgery: a decade experience at a large referral hospital. Head Neck 2002; 24: 684-93.
12. Epstein JI, Walsh PC, Sanfilippo F,. Clinical and cost impact of second-opinion pathology: review of prostate biopsies prior to radical prostatectomy. Am J Surg Pathol 1996; 20: 851-7.
13. Murphy WM, Rivera-Ramirez I, Luciani LG, et al,. Second opinion of anatomical pathology: a complex issue not easily reduced to matters of right and wrong. J Urol 2001; 165: 1957-9.
14. Verkooijen HM, Peterse JL, Schipper MEI, et al,. Interobserver variability between general and expert pathologists during the histopathological assessment of large-core needle and open biopsies of nonpalpable breast lesions. Eur J Cancer 2003; 39: 2187-91.
15. Berx G, Cleton-Jansen AM, Strumane K, et al,. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 1996; 13: 1919-25.
16. Lerwill MF,. Current practical applications of diagnostic immunohistochemistry in breast pathology. Am J Surg Pathol 2004; 28: 1076-91.
17. Page DL, Dupont WD, Rogers LW, Rados MS,. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 1985; 55: 2698-708.
18. Tavassoli FA, Norris HJ,. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 1990; 65: 518-29.
19. Schnitt SJ, Collins LC, Lakhani SR, Simpson PT,. Flat epithelial atypia. In:, Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ, eds. WHO Classification of Tumors of the Breast. Lyon, France: IARC Press, 2012: 87.
20. Schnitt SJ, Ellis IO, van de Vijver MJ, et al,. Intraductal proliferative lesions: introduction and overview. In:, Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ, eds. WHO Classification of Tumors of the Breast. Lyon, France: IARC Press, 2012: 82-3.
21. Lakhani SR, Schnitt SJ, O'malley F, van de Vijver MJ, Simpson PT,. Lobular neoplasia. In:, Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ, eds. WHO Classification of Tumors of the Breast. Lyon, France: IARC Press, 2012: 78-80.
22. Jacobs TW, Chen YY, Guinee DG Jr, et al,. Fibroepithelial lesions with cellular stroma on breast core needle biopsy: are there predictors of outcome on surgical excision? Am J Clin Pathol 2005; 124: 342-54.
23. Harvey JM, Clark GM, Osborne CK, Allred DC,. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999; 17: 1474-81.
24. Wolff AC, Hammond ME, Schwartz JN, et al,. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007; 25: 118-45.
25. Frable WF,. Surgical pathology-second reviews, institutional reviews, audits, and correlations. Arch Pathol Lab Med 2006; 130: 620-5.
26. Fletcher CDM,. Symposium on errors, error reduction, and critical values in anatomic pathology. Arch Pathol Lab Med 2006; 130: 602-3.
27. Cooper K,. Errors and error rates in surgical pathology, an Association of Directors of Anatomic and Surgical Pathology Survey. Arch Pathol Lab Med 2006; 130: 607-9.
28. Association of Directors of Anatomic and Surgical Pathology. Consultations in surgical pathology. Am J Surg Pathol 1993; 17: 743-5.
29. Hammond ME, Hayes DF, Dowsett M, Allred DC, et al,. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 2010; 28: 2784-95.
30. Seidman A, Hudis C, Pierri MK, et al,. Cardiac dysfunction in the trastuzumab clinical trials experience. J Clin Oncol 2002; 20: 1215.
31. Saul S,. Prone to error: earliest steps to find cancer. New York Times. July 19, 2010. Available at: http://www.nytimes.com/2010/07/20/health/20cancer.html?pagewanted=1&-r=0.
32. Collins LC, Connolly JL, Page D, et al,. Diagnostic agreement in the evaluation of image guided breast needle core biopsies: results from a randomized trial. Am J Surg Pathol 2004; 28: 126-31.
33. Masood S,. Why the term "low-grade ductal carcinoma in situ" should be changed to "borderline breast disease": diagnostic and clinical implications. Women's Health 2012; 8: 57-62.
34. Julien JP, Bijker N, Fentiman IS, et al,. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomized phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet 2000; 355: 528-33.
35. Hughes LL, Wang M, Page DL, et al,. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2009; 27: 5319-24.
36. Barrio AV, Clark BD, Goldberg JI, et al,. Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast. Ann Surg Oncol 2007; 14: 2961-70.
37. Tavassoli FA, Eusebi V,. Tumors of the Mammary Gland: Atlas of Tumor Pathology, 4th series, fascicle 10. Washington, DC: Armed Forces Institute of Pathology, 2009: 168.